330 related articles for article (PubMed ID: 17257271)
1. Mechanisms of protective effects induced by blockade of the renin-angiotensin system: novel role of the pancreatic islet angiotensin-generating system in Type 2 diabetes.
Leung PS
Diabet Med; 2007 Feb; 24(2):110-6. PubMed ID: 17257271
[TBL] [Abstract][Full Text] [Related]
2. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
Leiter LA; Lewanczuk RZ
Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
[TBL] [Abstract][Full Text] [Related]
3. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
4. Preventing diabetes in patients with hypertension: one more reason to block the renin-angiotensin system.
Cooper ME; Tikellis C; Thomas MC
J Hypertens Suppl; 2006 Mar; 24(1):S57-63. PubMed ID: 16601575
[TBL] [Abstract][Full Text] [Related]
5. Protection of pancreatic beta-cells: is it feasible?
Bonora E
Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
[TBL] [Abstract][Full Text] [Related]
6. Role of the renin-angiotensin system in the endocrine pancreas: implications for the development of diabetes.
Tikellis C; Cooper ME; Thomas MC
Int J Biochem Cell Biol; 2006; 38(5-6):737-51. PubMed ID: 16198140
[TBL] [Abstract][Full Text] [Related]
7. [Prevention of type 2 diabetes mellitus due to antihypertensive treatment affecting renin-angiotensin system].
Boucek P
Vnitr Lek; 2006 Sep; 52(9):791-6. PubMed ID: 17091602
[TBL] [Abstract][Full Text] [Related]
8. Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.
Balamuthusamy S; Srinivasan L; Verma M; Adigopula S; Jalandhara N; Hathiwala S; Smith E
Am Heart J; 2008 May; 155(5):791-805. PubMed ID: 18440325
[TBL] [Abstract][Full Text] [Related]
9. The therapeutic role of RAS blockade in chronic heart failure.
Werner CM; Böhm M
Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):167-77. PubMed ID: 19124420
[TBL] [Abstract][Full Text] [Related]
10. Does interference with the renin-angiotensin system protect against diabetes? Evidence and mechanisms.
van der Zijl NJ; Moors CC; Goossens GH; Blaak EE; Diamant M
Diabetes Obes Metab; 2012 Jul; 14(7):586-95. PubMed ID: 22226145
[TBL] [Abstract][Full Text] [Related]
11. The renin-angiotensin-aldosterone system: a pivotal role in insulin sensitivity and glycemic control.
Perkins JM; Davis SN
Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):147-52. PubMed ID: 18316950
[TBL] [Abstract][Full Text] [Related]
12. Anti-diabetic effect of blockade of the renin-angiotensin system.
Ando K; Fujita T
Diabetes Obes Metab; 2006 Jul; 8(4):396-403. PubMed ID: 16776746
[TBL] [Abstract][Full Text] [Related]
13. Prevention of remodeling in congestive heart failure due to myocardial infarction by blockade of the renin-angiotensin system.
Guo X; Saini HK; Wang J; Gupta SK; Goyal RK; Dhalla NS
Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):717-32. PubMed ID: 16076281
[TBL] [Abstract][Full Text] [Related]
14. The role of the renin-angiotensin-aldosterone system in diabetes and its vascular complications.
Cooper ME
Am J Hypertens; 2004 Nov; 17(11 Pt 2):16S-20S; quiz A2-4. PubMed ID: 15539106
[TBL] [Abstract][Full Text] [Related]
15. The role of renin-angiotensin-aldosterone system-based therapy in diabetes prevention and cardiovascular and renal protection.
Abuissa H; O'Keefe J
Diabetes Obes Metab; 2008 Dec; 10(12):1157-66. PubMed ID: 18494810
[TBL] [Abstract][Full Text] [Related]
16. Renin-angiotensin-system blockade in the prevention of diabetes.
Ostergren J
Diabetes Res Clin Pract; 2007 May; 76 Suppl 1():S13-21. PubMed ID: 17320999
[TBL] [Abstract][Full Text] [Related]
17. [RAAS and insulin resistance].
Motoshima H; Araki E
Nihon Rinsho; 2012 Sep; 70(9):1542-9. PubMed ID: 23012801
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting the renin-angiotensin system: why and in which patients.
Berra K; Miller NH
J Am Acad Nurse Pract; 2009 Jan; 21(1):66-75. PubMed ID: 19125897
[TBL] [Abstract][Full Text] [Related]
19. How to explain the differences between renin angiotensin system modulators.
Levy BI
Am J Hypertens; 2005 Sep; 18(9 Pt 2):134S-141S. PubMed ID: 16125050
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
Vijan SG
J Indian Med Assoc; 2009 Mar; 107(3):178-82. PubMed ID: 19810392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]